United States faces biggest burden of hepatitis C treatment costs before 2020
United States faces biggest burden of hepatitis C treatment costs before 2020
- They argue that this cost is substantially cheaper than the cost of HIV treatment and prevention during the period of 2011 to 2015 ($144 billion).
- They argue that this cost is substantially cheaper than the cost of HIV treatment and prevention during the period of 2011 to 2015 ($144 billion).